M&T Bank
TXG icon

M&T Bank’s 10x Genomics TXG Stock Holding History

M&T Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Sell
20,536
-1,163
-5% -$23.3K ﹤0.01% 1177
2025
Q4 		$354K Buy
21,699
+1,282
+6% +$19.4K ﹤0.01% 1298
2025
Q3 		$238K Sell
20,417
-469
-2% -$6.12K ﹤0.01% 1311
2025
Q2 		$241K Buy
+20,886
New +$190K ﹤0.01% 1365
2024
Q4 		– Sell
-9,008
Closed -$203K – 1693
2024
Q3 		$203K Buy
+9,008
New +$186K ﹤0.01% 1515
2024
Q1 		– Sell
-4,501
Closed -$252K – 1683
2023
Q4 		$252K Buy
+4,501
New +$196K ﹤0.01% 1391
2023
Q3 		– Sell
-3,860
Closed -$215K – 1667
2023
Q2 		$215K Buy
3,860
+190
+5% +$10.3K ﹤0.01% 1444
2023
Q1 		$204K Buy
+3,670
New +$171K ﹤0.01% 1469
2022
Q2 		– Sell
-2,916
Closed -$222K – 1703
2022
Q1 		$222K Buy
2,916
+860
+42% +$75.2K ﹤0.01% 1346
2021
Q4 		$305K Sell
2,056
-55
-3% -$8.42K ﹤0.01% 1242
2021
Q3 		$307K Buy
2,111
+11
+0.5% +$1.89K ﹤0.01% 1221
2021
Q2 		$412K Buy
2,100
+287
+16% +$51.9K ﹤0.01% 1115
2021
Q1 		$328K Buy
1,813
+104
+6% +$18K ﹤0.01% 1202
2020
Q4 		$242K Buy
+1,709
New +$248K ﹤0.01% 1423

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&T Bank's TXG Position: Q1 2026 in Review

M&T Bank reduced its 10x Genomics (TXG) stake by 5.4% in Q1 2026, selling an estimated $23.3K and leaving 20,536 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

M&T Bank first reported a position in TXG in Q4 2020 and has held it in 14 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • M&T Bank held 20,536 shares of 10x Genomics worth $436K as of Q1 2026.
  • M&T Bank sold 1,163 10x Genomics shares in Q1 2026, an estimated $23.3K.
  • 10x Genomics made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1177 holding.
  • M&T Bank first reported a position in 10x Genomics in Q4 2020 and has held it in 14 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.